471 related articles for article (PubMed ID: 17611291)
1. NF-kappaB as a potential molecular target for cancer therapy.
Lee CH; Jeon YT; Kim SH; Song YS
Biofactors; 2007; 29(1):19-35. PubMed ID: 17611291
[TBL] [Abstract][Full Text] [Related]
2. NF-kappaB and IKK as therapeutic targets in cancer.
Kim HJ; Hawke N; Baldwin AS
Cell Death Differ; 2006 May; 13(5):738-47. PubMed ID: 16485028
[TBL] [Abstract][Full Text] [Related]
3. IKK/NF-kappaB signaling: balancing life and death--a new approach to cancer therapy.
Luo JL; Kamata H; Karin M
J Clin Invest; 2005 Oct; 115(10):2625-32. PubMed ID: 16200195
[TBL] [Abstract][Full Text] [Related]
4. NF-kappaB as a therapeutic target in cancer.
Orlowski RZ; Baldwin AS
Trends Mol Med; 2002 Aug; 8(8):385-9. PubMed ID: 12127724
[TBL] [Abstract][Full Text] [Related]
5. NF-κB signaling in cancer stem cells: a promising therapeutic target?
Vazquez-Santillan K; Melendez-Zajgla J; Jimenez-Hernandez L; Martínez-Ruiz G; Maldonado V
Cell Oncol (Dordr); 2015 Oct; 38(5):327-39. PubMed ID: 26318853
[TBL] [Abstract][Full Text] [Related]
6. NF-κB Signaling Pathway Inhibitors as Anticancer Drug Candidates.
de Castro Barbosa ML; da Conceicao RA; Fraga AGM; Camarinha BD; de Carvalho Silva GC; Lima AGF; Cardoso EA; de Oliveira Freitas Lione V
Anticancer Agents Med Chem; 2017; 17(4):483-490. PubMed ID: 27481554
[TBL] [Abstract][Full Text] [Related]
7. N-(4-hydroxyphenyl)retinamide inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of I(kappa)B(alpha) kinase and nuclear factor-kappaB-regulated gene products.
Shishodia S; Gutierrez AM; Lotan R; Aggarwal BB
Cancer Res; 2005 Oct; 65(20):9555-65. PubMed ID: 16230421
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of nuclear translocation of nuclear factor-kappaB despite lack of functional IkappaBalpha protein overcomes multiple defects in apoptosis signaling in human B-cell malignancies.
Thomas RK; Sos ML; Zander T; Mani O; Popov A; Berenbrinker D; Smola-Hess S; Schultze JL; Wolf J
Clin Cancer Res; 2005 Nov; 11(22):8186-94. PubMed ID: 16299251
[TBL] [Abstract][Full Text] [Related]
9. Targeting NF-κB signaling pathway in cancer by dietary polyphenols.
Khan H; Ullah H; Castilho PCMF; Gomila AS; D'Onofrio G; Filosa R; Wang F; Nabavi SM; Daglia M; Silva AS; Rengasamy KRR; Ou J; Zou X; Xiao J; Cao H
Crit Rev Food Sci Nutr; 2020; 60(16):2790-2800. PubMed ID: 31512490
[TBL] [Abstract][Full Text] [Related]
10. The NF-kappaB/IkappaB signaling system: a molecular target in breast cancer therapy.
Wu JT; Kral JG
J Surg Res; 2005 Jan; 123(1):158-69. PubMed ID: 15652965
[TBL] [Abstract][Full Text] [Related]
11. Embelin, an inhibitor of X chromosome-linked inhibitor-of-apoptosis protein, blocks nuclear factor-kappaB (NF-kappaB) signaling pathway leading to suppression of NF-kappaB-regulated antiapoptotic and metastatic gene products.
Ahn KS; Sethi G; Aggarwal BB
Mol Pharmacol; 2007 Jan; 71(1):209-19. PubMed ID: 17028156
[TBL] [Abstract][Full Text] [Related]
12. Isodeoxyelephantopin, a novel sesquiterpene lactone, potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis through suppression of nuclear factor-kappaB (nf-kappaB) activation and nf-kappaB-regulated gene expression.
Ichikawa H; Nair MS; Takada Y; Sheeja DB; Kumar MA; Oommen OV; Aggarwal BB
Clin Cancer Res; 2006 Oct; 12(19):5910-8. PubMed ID: 17021000
[TBL] [Abstract][Full Text] [Related]
13. Dynamic advances in NF-kappaB signaling analysis.
Kobayashi T; Kageyama R
Sci Signal; 2009 Jul; 2(81):pe47. PubMed ID: 19638614
[TBL] [Abstract][Full Text] [Related]
14. NF-κB in cancer therapy.
Li F; Zhang J; Arfuso F; Chinnathambi A; Zayed ME; Alharbi SA; Kumar AP; Ahn KS; Sethi G
Arch Toxicol; 2015 May; 89(5):711-31. PubMed ID: 25690730
[TBL] [Abstract][Full Text] [Related]
15. Fisetin, an inhibitor of cyclin-dependent kinase 6, down-regulates nuclear factor-kappaB-regulated cell proliferation, antiapoptotic and metastatic gene products through the suppression of TAK-1 and receptor-interacting protein-regulated IkappaBalpha kinase activation.
Sung B; Pandey MK; Aggarwal BB
Mol Pharmacol; 2007 Jun; 71(6):1703-14. PubMed ID: 17387141
[TBL] [Abstract][Full Text] [Related]
16. Inhibiting NF-κB activation by small molecules as a therapeutic strategy.
Gupta SC; Sundaram C; Reuter S; Aggarwal BB
Biochim Biophys Acta; 2010; 1799(10-12):775-87. PubMed ID: 20493977
[TBL] [Abstract][Full Text] [Related]
17. Regulation and function of IKK and IKK-related kinases.
Häcker H; Karin M
Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
[TBL] [Abstract][Full Text] [Related]
18. Targeting Oncogenic Nuclear Factor Kappa B Signaling with Redox-Active Agents for Cancer Treatment.
Fouani L; Kovacevic Z; Richardson DR
Antioxid Redox Signal; 2019 Mar; 30(8):1096-1123. PubMed ID: 29161883
[TBL] [Abstract][Full Text] [Related]
19. Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls.
Baud V; Karin M
Nat Rev Drug Discov; 2009 Jan; 8(1):33-40. PubMed ID: 19116625
[TBL] [Abstract][Full Text] [Related]
20. Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosis.
Pandey MK; Sung B; Kunnumakkara AB; Sethi G; Chaturvedi MM; Aggarwal BB
Cancer Res; 2008 Jul; 68(13):5370-9. PubMed ID: 18593939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]